highly significantp < 0.001
There were highly significant differences in the changes in LSBMDz at one year between the three groups; risedronate vs 1-alfacalcidol (difference 0.34; p < 0.001) and risedronate vs Placebo (difference 0.27; P < 0.01).
There were highly significant differences in the changes in LSBMDz at one year between the three groups; risedronate vs 1-alfacalcidol (difference 0.34; p < 0.001) and risedronate vs Placebo (difference 0.27; P < 0.01).
A statistical trend of significance was observed between limited MMO and acute TMJ arthritis (p 0.09). 70.5% of the patients included had al least two positive clinical or physical examination items.
But this did not reach statistical significance.
Compared to those who had not achieved CID, children who had achieved CID on both tools at one year showed a trend to improved CHAQ scores at five years.